Crossmark

Role of the neutrophil/lymphocyte ratio in patients with metastatic castration-resistant prostate cancer treated first-line with abiraterone

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2019.11.002

Published Print: 2020-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Nieblas-Toscano, D.

Arenas-Bonilla, A.J.

Flores-Martín, J.F.

Gutiérrez-Tejero, F.

Velarde-Muñoz, C.

Ramos-Alaminos, C.I.

Salas-Moreno, M.C.

Galisteo-Moya, R.

Moreno-Jiménez, J.
License Information

Text and Data Mining valid from 2020-04-01
More Information

This article is maintained by: Elsevier

Article Title: Role of the neutrophil/lymphocyte ratio in patients with metastatic castration-resistant prostate cancer treated first-line with abiraterone

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2019.11.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2019.11.003

Content Type: article

Copyright: © 2019 AEU. Published by Elsevier España, S.L.U. All rights reserved.